Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium

BACKGROUND: Human papillomavirus type 16 (HPV16)-E6 antibodies are detectable in peripheral blood before diagnosis in the majority of HPV16-driven oropharyngeal squamous cell carcinoma (OPSCC), but the timing of seroconversion is unknown. PATIENTS AND METHODS: We formed the HPV Cancer Cohort Consort...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreimer, A R, Ferreiro-Iglesias, A, Nygard, M, Bender, N, Schroeder, L, Hildesheim, A, Robbins, H A, Pawlita, M, Langseth, H, Schlecht, N F, Tinker, L F, Agalliu, I, Smoller, S W, Ness-Jensen, E, Hveem, K, D’Souza, G, Visvanathan, K, May, B, Ursin, G, Weiderpass, E, Giles, G G, Milne, R L, Cai, Q, Blot, W J, Zheng, W, Weinstein, S J, Albanes, D, Brenner, N, Hoffman-Bolton, J, Kaaks, R, Barricarte, A, Tjønneland, A, Sacerdote, C, Trichopoulou, A, Vermeulen, R C H, Huang, W -Y, Freedman, N D, Brennan, P, Waterboer, T, Johansson, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683856/
https://www.ncbi.nlm.nih.gov/pubmed/31185496
http://dx.doi.org/10.1093/annonc/mdz138

Ejemplares similares

Ejemplares similares